RMDN1
gene geneOn this page
Also known as CGI-90FLJ20665RMD1
Summary
RMDN1 (regulator of microtubule dynamics 1, HGNC:24285) is a protein-coding gene on chromosome 8q21.3, encoding Regulator of microtubule dynamics protein 1 (Q96DB5).
Enables microtubule binding activity. Predicted to be involved in attachment of mitotic spindle microtubules to kinetochore and mitotic spindle organization. Located in mitotic spindle pole and spindle microtubule.
Source: NCBI Gene 51115 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_016033
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24285 |
| Approved symbol | RMDN1 |
| Name | regulator of microtubule dynamics 1 |
| Location | 8q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-90, FLJ20665, RMD1 |
| Ensembl gene | ENSG00000176623 |
| Ensembl biotype | protein_coding |
| OMIM | 611871 |
| Entrez | 51115 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 19 protein_coding, 4 retained_intron, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000406452, ENST00000430676, ENST00000517404, ENST00000517710, ENST00000517821, ENST00000518390, ENST00000518772, ENST00000519145, ENST00000519247, ENST00000519639, ENST00000519789, ENST00000519966, ENST00000520719, ENST00000521045, ENST00000522804, ENST00000522942, ENST00000523370, ENST00000523911, ENST00000524172, ENST00000902719, ENST00000902720, ENST00000902721, ENST00000902722, ENST00000902723, ENST00000949087, ENST00000949088, ENST00000949089
RefSeq mRNA: 4 — MANE Select: NM_016033
NM_001286707, NM_001286719, NM_001317807, NM_016033
CCDS: CCDS34918, CCDS69509, CCDS69510, CCDS83305
Canonical transcript exons
ENST00000406452 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001289651 | 86508492 | 86508686 |
| ENSE00001756516 | 86477294 | 86477324 |
| ENSE00001782437 | 86478923 | 86479010 |
| ENSE00002096442 | 86472349 | 86474358 |
| ENSE00003466803 | 86488552 | 86488639 |
| ENSE00003582079 | 86480277 | 86480332 |
| ENSE00003586379 | 86506995 | 86507112 |
| ENSE00003616877 | 86484872 | 86484961 |
| ENSE00003637811 | 86486484 | 86486643 |
| ENSE00003689877 | 86474820 | 86474953 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 96.90.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 40.0785 / max 193.3241, expressed in 1821 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 93816 | 36.4279 | 1821 |
| 93818 | 1.8456 | 1158 |
| 93817 | 1.0296 | 765 |
| 93820 | 0.7141 | 350 |
| 93819 | 0.0612 | 10 |
Top tissues by expression
287 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 96.90 | gold quality |
| tendon | UBERON:0000043 | 96.51 | gold quality |
| adrenal tissue | UBERON:0018303 | 96.41 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.19 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.04 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.01 | gold quality |
| tibial nerve | UBERON:0001323 | 96.00 | gold quality |
| rectum | UBERON:0001052 | 95.92 | gold quality |
| right lobe of liver | UBERON:0001114 | 95.86 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 95.82 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.80 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.76 | gold quality |
| muscle of leg | UBERON:0001383 | 95.75 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.62 | gold quality |
| heart right ventricle | UBERON:0002080 | 95.56 | gold quality |
| thyroid gland | UBERON:0002046 | 95.51 | gold quality |
| right atrium auricular region | UBERON:0006631 | 95.41 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.11 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.03 | gold quality |
| heart | UBERON:0000948 | 94.92 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.88 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.75 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.66 | gold quality |
| cardiac atrium | UBERON:0002081 | 94.43 | gold quality |
| lower esophagus | UBERON:0013473 | 94.40 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 94.39 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 94.36 | gold quality |
| esophagus mucosa | UBERON:0002469 | 94.24 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 94.23 | gold quality |
| esophagus | UBERON:0001043 | 94.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
55 targeting RMDN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-4530 | 99.69 | 66.47 | 1509 |
| HSA-MIR-4502 | 99.65 | 66.99 | 1021 |
| HSA-MIR-5003-5P | 99.61 | 69.13 | 1624 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-548AS-3P | 99.12 | 69.12 | 2294 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rmdn1 | ENSDARG00000074507 |
| mus_musculus | Rmdn1 | ENSMUSG00000028229 |
| rattus_norvegicus | Rmdn1 | ENSRNOG00000025145 |
| caenorhabditis_elegans | F33H2.6 | WBGENE00009369 |
Paralogs (3): RMDN2 (ENSG00000115841), TEX10 (ENSG00000136891), RMDN3 (ENSG00000137824)
Protein
Protein identifiers
Regulator of microtubule dynamics protein 1 — Q96DB5 (reviewed: Q96DB5)
Alternative names: Protein FAM82B
All UniProt accessions (12): Q96DB5, E5RGC8, E5RH53, E5RJC7, E5RJV0, E7EWZ7, H0YAP5, H0YB03, H0YB83, H0YBD9, H0YC27, H0YC67
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with microtubules.
Subcellular location. Cytoplasm. Cytoskeleton. Spindle. Spindle pole.
Similarity. Belongs to the RMDN family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96DB5-1 | 1 | yes |
| Q96DB5-2 | 2 | |
| Q96DB5-3 | 3 |
RefSeq proteins (4): NP_001273636, NP_001273648, NP_001304736, NP_057117* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR049039 |
Pfam: PF21033
UniProt features (9 total): repeat 2, splice variant 2, sequence conflict 2, chain 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96DB5-F1 | 84.49 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 165
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 144 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, GOBP_CHROMOSOME_ORGANIZATION, GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE, GOBP_CHROMOSOME_LOCALIZATION, MATTIOLI_MGUS_VS_PCL, GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP, GOCC_MICROTUBULE_ORGANIZING_CENTER, ONKEN_UVEAL_MELANOMA_UP, GOBP_ORGANELLE_FISSION, GOCC_CENTROSOME, GOBP_MITOTIC_NUCLEAR_DIVISION, GOBP_MITOTIC_CELL_CYCLE, CUI_TCF21_TARGETS_2_DN, ACEVEDO_LIVER_CANCER_UP, GOBP_ORGANELLE_LOCALIZATION
GO Biological Process (2): mitotic spindle organization (GO:0007052), attachment of mitotic spindle microtubules to kinetochore (GO:0051315)
GO Molecular Function (2): microtubule binding (GO:0008017), protein binding (GO:0005515)
GO Cellular Component (8): cytoplasm (GO:0005737), mitochondrion (GO:0005739), spindle microtubule (GO:0005876), mitotic spindle pole (GO:0097431), spindle pole (GO:0000922), spindle (GO:0005819), cytoskeleton (GO:0005856), microtubule (GO:0005874)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| spindle | 2 |
| microtubule cytoskeleton | 2 |
| intracellular membraneless organelle | 2 |
| mitotic cell cycle | 1 |
| spindle organization | 1 |
| microtubule cytoskeleton organization involved in mitosis | 1 |
| mitotic metaphase chromosome alignment | 1 |
| attachment of spindle microtubules to kinetochore | 1 |
| mitotic cell cycle process | 1 |
| tubulin binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| microtubule | 1 |
| spindle pole | 1 |
| mitotic spindle | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
1660 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RMDN1 | ARMC1 | Q9NVT9 | 550 |
| RMDN1 | PTPN2 | P17706 | 546 |
| RMDN1 | MRPL13 | Q9BYD1 | 510 |
| RMDN1 | TMEM70 | Q9BUB7 | 501 |
| RMDN1 | VCPIP1 | Q96JH7 | 496 |
| RMDN1 | FAM91A1 | Q658Y4 | 479 |
| RMDN1 | RRS1 | Q15050 | 475 |
| RMDN1 | AURKB | Q96GD4 | 458 |
| RMDN1 | ELOC | Q15369 | 437 |
| RMDN1 | PTPN1 | P18031 | 428 |
| RMDN1 | PARP1 | P09874 | 424 |
| RMDN1 | UBE2V2 | Q15819 | 416 |
| RMDN1 | TIGD5 | Q53EQ6 | 414 |
| RMDN1 | PGBD4 | Q96DM1 | 399 |
| RMDN1 | CPNE3 | O75131 | 375 |
IntAct
37 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SUZ12 | EED | psi-mi:“MI:0914”(association) | 0.910 |
| HRAS | MTHFD2 | psi-mi:“MI:0914”(association) | 0.730 |
| NRAS | RGL2 | psi-mi:“MI:0914”(association) | 0.550 |
| CYP2E1 | RMDN1 | psi-mi:“MI:0914”(association) | 0.530 |
| RMDN1 | LUM | psi-mi:“MI:0915”(physical association) | 0.400 |
| Myh9 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK2 | BLTP3B | psi-mi:“MI:0914”(association) | 0.350 |
| Junb | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| CHIT1 | VHL | psi-mi:“MI:0914”(association) | 0.350 |
| H2AX | ANXA6 | psi-mi:“MI:0914”(association) | 0.350 |
| HTRA4 | PSMD12 | psi-mi:“MI:0914”(association) | 0.350 |
| DDB1 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| SAR1B | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| S100P | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| S100A6 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| CENPM | DNM1L | psi-mi:“MI:0914”(association) | 0.350 |
| TOP3B | PRMT5 | psi-mi:“MI:0914”(association) | 0.350 |
| CHIT1 | SMAD7 | psi-mi:“MI:0914”(association) | 0.350 |
| NIPA2 | SYNGR2 | psi-mi:“MI:0914”(association) | 0.350 |
| ANLN | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| SERBP1 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| NTNG1 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| WIF1 | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
| SYT6 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| XPA | ENSA | psi-mi:“MI:0914”(association) | 0.350 |
| CABCOCO1 | NARS1 | psi-mi:“MI:0914”(association) | 0.350 |
| PDLIM5 | ZMPSTE24 | psi-mi:“MI:0914”(association) | 0.350 |
| PAQR3 | AGFG1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (60): RMDN1 (Co-fractionation), SHC1 (Co-fractionation), RMDN1 (Synthetic Growth Defect), RMDN1 (Affinity Capture-MS), RMDN1 (Affinity Capture-MS), RMDN1 (Affinity Capture-MS), RMDN1 (Affinity Capture-MS), RMDN1 (Affinity Capture-MS), RMDN1 (Affinity Capture-MS), RMDN1 (Proximity Label-MS), RMDN1 (Proximity Label-MS), SUZ12 (Affinity Capture-MS), EED (Affinity Capture-MS), RMDN1 (Affinity Capture-MS), EZH2 (Affinity Capture-MS)
ESM2 similar proteins: A1A4L1, A4QP75, B0S6U7, E1BPN0, E7FCP8, O00142, O55171, P0C1Q3, P19686, P19687, P33402, P49753, P57075, Q02108, Q08CH3, Q1L5Z9, Q1LWG4, Q3B8B2, Q3SZV6, Q3UUI3, Q4V8A1, Q4ZHS0, Q502J0, Q566R0, Q58CX2, Q5IRJ6, Q5R4H0, Q5R8E4, Q5SY16, Q5ZIU8, Q60963, Q63159, Q66GI4, Q6GLK2, Q6PML9, Q6TEC1, Q810S1, Q8BMS4, Q8BWM0, Q8N159
Diamond homologs: P34560, Q0P4W3, Q2TBQ7, Q32KL4, Q4G069, Q5R8E4, Q96DB5, Q9DCV4, Q1JQC5, Q3UJU9, Q498D5, Q5EAU9, Q5R6Z1, Q66H15, Q8BSE0, Q95LL7, Q96LZ7, Q96TC7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2459 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:86474815:TTTA:T | donor_loss | 1.0000 |
| 8:86474817:TACC:T | donor_loss | 1.0000 |
| 8:86474819:CC:C | donor_loss | 1.0000 |
| 8:86474954:C:CC | acceptor_gain | 1.0000 |
| 8:86486479:CTCA:C | donor_loss | 1.0000 |
| 8:86486480:TCACC:T | donor_loss | 1.0000 |
| 8:86486482:A:AC | donor_gain | 1.0000 |
| 8:86486482:A:AT | donor_loss | 1.0000 |
| 8:86486482:AC:A | donor_gain | 1.0000 |
| 8:86486483:C:CC | donor_gain | 1.0000 |
| 8:86486483:CC:C | donor_gain | 1.0000 |
| 8:86486483:CCTT:C | donor_gain | 1.0000 |
| 8:86486639:CTTCA:C | acceptor_gain | 1.0000 |
| 8:86486640:TTCA:T | acceptor_gain | 1.0000 |
| 8:86486641:TCA:T | acceptor_gain | 1.0000 |
| 8:86486642:CA:C | acceptor_gain | 1.0000 |
| 8:86486642:CAC:C | acceptor_gain | 1.0000 |
| 8:86486643:ACTA:A | acceptor_loss | 1.0000 |
| 8:86486644:C:CC | acceptor_gain | 1.0000 |
| 8:86486647:A:AC | acceptor_gain | 1.0000 |
| 8:86486647:A:C | acceptor_gain | 1.0000 |
| 8:86486648:T:C | acceptor_gain | 1.0000 |
| 8:86486648:T:TC | acceptor_gain | 1.0000 |
| 8:86486649:T:C | acceptor_gain | 1.0000 |
| 8:86486649:T:TC | acceptor_gain | 1.0000 |
| 8:86486654:A:AC | acceptor_gain | 1.0000 |
| 8:86486654:A:C | acceptor_gain | 1.0000 |
| 8:86488546:GCTT:G | donor_loss | 1.0000 |
| 8:86488547:CTTAC:C | donor_loss | 1.0000 |
| 8:86488548:TTACC:T | donor_loss | 1.0000 |
AlphaMissense
2034 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:86480329:C:G | A197P | 0.997 |
| 8:86484954:G:T | A168E | 0.997 |
| 8:86484961:A:G | W166R | 0.997 |
| 8:86484961:A:T | W166R | 0.997 |
| 8:86480284:C:G | G212R | 0.996 |
| 8:86474866:A:G | L283P | 0.995 |
| 8:86486611:C:G | R123P | 0.995 |
| 8:86474914:C:T | G267E | 0.994 |
| 8:86474915:C:G | G267R | 0.994 |
| 8:86474915:C:T | G267R | 0.994 |
| 8:86474928:G:C | N262K | 0.994 |
| 8:86474928:G:T | N262K | 0.994 |
| 8:86480289:A:G | L210P | 0.994 |
| 8:86486620:C:G | R120P | 0.994 |
| 8:86486621:G:T | R120S | 0.994 |
| 8:86477303:C:G | A251P | 0.993 |
| 8:86480278:A:G | W214R | 0.993 |
| 8:86480278:A:T | W214R | 0.993 |
| 8:86480283:C:T | G212D | 0.993 |
| 8:86486602:C:G | R126P | 0.993 |
| 8:86486624:A:G | W119R | 0.993 |
| 8:86486624:A:T | W119R | 0.993 |
| 8:86488619:C:G | A90P | 0.993 |
| 8:86474940:G:C | F258L | 0.992 |
| 8:86474940:G:T | F258L | 0.992 |
| 8:86474942:A:G | F258L | 0.992 |
| 8:86486484:C:A | K165N | 0.992 |
| 8:86486484:C:G | K165N | 0.992 |
| 8:86486522:C:G | A153P | 0.992 |
| 8:86484955:C:G | A168P | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000210785 (8:86509157 G>T), RS1000245737 (8:86504532 A>G), RS1000256821 (8:86481062 A>G), RS1000286794 (8:86512443 T>C), RS1000299350 (8:86504278 C>G,T), RS1000307787 (8:86481432 G>T), RS1000390297 (8:86505758 C>T), RS1000445000 (8:86512051 GTGAA>G), RS1000542052 (8:86498866 C>T), RS1000620857 (8:86510928 A>C), RS1000643471 (8:86479858 G>C), RS1000750690 (8:86472803 C>A,T), RS1000776512 (8:86510641 C>G), RS1000821257 (8:86474148 C>G,T), RS1000846173 (8:86476240 T>A)
Disease associations
OMIM: gene MIM:611871 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005316_88 | Intelligence (MTAG) | 2.000000e-08 |
| GCST006585_371 | Blood protein levels | 5.000000e-313 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| bisphenol F | increases expression, affects cotreatment | 2 |
| bisphenol A | decreases expression, affects cotreatment, increases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenate | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| methylparaben | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol S | increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cadmium | increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Rotenone | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.